This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Reckitt Benckiser settles with NHS in Scotland, Wales and Northern Ireland

( May 14, 2014, 08:55 GMT | Official Statement) -- MLex Summary: Reckitt Benckiser and the Scottish Ministers, the Welsh Ministers, and the Department of Health, Social Services and Public Protection for Northern Ireland, Regional Health and Social Care Board announced that they have settled the claims brought against Reckitt Benckiser in connection with the supply of heartburn drug Gaviscon to the NHS in Scotland, Wales and Northern Ireland. The parties added that Reckitt Benckiser will make a payment to the Devolved NHS on a full and final basis.The full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections